Catheter Precision Inc. (NYSEAMERICAN: VTAK) shares jumped 19.36% to $0.67 after the bell on Tuesday.
The surge in the late trading session follows an intraday decline of 13.90%, where the stock of the medical device company closed at $0.56, according to Benzinga Pro data.
Trading volume for the day increased to 23.68 million shares, about 1.7 times the stock’s average daily volume of 13.70 million shares, indicating higher-than-usual trading activity.
The stock move followed a Jul. 10 prospectus filed with the Securities and Exchange Commission that registers resale of 68.06 million common shares tied to Series C, D and J preferred stock conversions, Series M warrant exercises, and previously issued common shares.
Dilution Risk Takes Center Stage
Most of the shares stem from financing agreements with unnamed accredited investors and acquisition agreements with SEGJets SPVI LLC and Creatd, Inc., dated Feb. 6 and Mar. 9. The total also includes shares tied to Series J preferred stock and Series M warrants.
The filing warns the issuance “could cause substantial dilution” to existing stockholders.
Prospectus Details
According to the filing, the prospectus lists a par value of $0.0001 per share for the common stock. No underwriter is involved in the offering, and selling stockholders will retain all proceeds from any resale of shares.
In July, Catheter Precision announced a LifeVac airway-clearance device partnership for its Flyte aircraft unit.
Trading Metrics, Technical Analysis
Catheter Precision has a market capitalization of $2.02 million, with a 52-week high of $4.94 and a 52-week low of $0.55.
The Relative Strength Index (RSI) of VTAK stands at 39.36, while short interest is at 8.30%.
Over the past 12 months, the stock has dropped 86.79%.
VTAK is currently near its annual low.
The stock’s significant decline and weak market position suggest continued pressure. This reflects increased risk and indicates that clearer signs of recovery may be needed before investor confidence returns.
Benzinga’s Edge Stock Rankings indicate that VTAK has a negative price trend across all time frames.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo Courtesy: Wahyu Aditya147 on Shutterstock.com
Login to comment